Andrew Mumford is Professor of Haematology at the University of Bristol and a Consultant in Haemostasis and Thrombosis at University Hospitals Bristol and Weston. He is also the Research Director of the SW NHS Genomic Medicine Service alliance, which is responsible for driving uptake of rare disease and cancer genomic medicine to the 5M population of SW England. Andrew co-leads the Bleeding and Platelet disorders programme in the NIHR rare disease BioResource and the Genomics England Haematology GeCIP. He is the director of the HEE-NIHR Clinical academic training programme for Haematology within the Severn Deanery and hosts four current clinical PhD students. Andrew’s research focusses on rare inherited blood and cardiovascular disorders and population genetics of blood cell and thrombosis traits. He has more than 150 peer reviewd publications and an H index of 52.